Endoscopy-related infections and toxic reactions: An international comparison

Endoscopy

Volumn 39, Issue 8, 2007, Pages 742-746

  Seoane Vazquez, E ^a   Rodriguez Monguio, R ^a   Visaria, J ^a   Carlson, A ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; COMPARATIVE STUDY; DATA BASE; DISINFECTION; ENDOSCOPY; FOOD AND DRUG ADMINISTRATION; HUMAN; INFECTION COMPLICATION; MEDLINE; PRIORITY JOURNAL; PSEUDOINFECTION; REVIEW; SCIENTIFIC LITERATURE; BACTERIAL INFECTION; CROSS INFECTION; EPIDEMIC; EQUIPMENT; FEMALE; INCIDENCE; INFECTION CONTROL; INTERNATIONAL COOPERATION; MALE; METHODOLOGY; MICROBIOLOGY; STATISTICS; UNITED STATES;

BACTERIAL INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; DISINFECTION; ENDOSCOPY; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; INCIDENCE; INFECTION CONTROL; INTERNATIONAL COOPERATION; MALE; UNITED STATES;

EID: 34548043041     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-966504     Document Type: Review

References (27)

1. Muscarella LF. Dear Los Angeles Times: the risk of disease transmission during gastrointestinal endoscopy. Gastroenterol Nurs 2004; 27: 271-278
2. Nelson DB. Infection control during gastrointestinal endoscopy. J Lab Clin Med 2003; 141: 159-167
3. Cronmiller JR, Nelson DK, Salman G et al. Antimicrobial efficacy of endoscopic disinfection procedures: a controlled, multifactorial investigation. Gastrointest Endosc 1999; 50: 152-158
4. Foliente RL, Kovacs BJ, Aprecio RM et al. Efficacy of high-level disinfectants for reprocessing gastrointestinal endoscopes in simulated-use testing. Gastrointest Endosc 2001; 53: 456-462
5. Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993; 118: 117-128
6. Prakash UB. Does the bronchoscope propagate infection? Chest 1993; 104: 552-559
7. Nelson DB. Infectious disease complications of GI endoscopy: part I, endogenous infections. Gastrointest Endosc 2003; 57: 546-556
8. Vennes JA. Infectious complications of gastrointestinal endoscopy. Dig Dis Sci 1981; 26 (7 Suppl): 60S-64S
9. Favero MS. Strategies for disinfection and sterilization of endoscopes: the gap between basic principles and actual practice. Infect Control Hosp Epidemiol 1991; 12: 279-281
10. Axon AT. Working Party Report to the World Congresses. Disinfection and endoscopy: summary and recommendations. J Gastroenterol Hepatol 1991; 6: 23-24
11. Pajkos A, Vickery K, Cossart Y. Is biofilm accumulation on endoscope tubing a contributor to the failure of cleaning and decontamination? J Hosp Infect 2004; 58: 224-229
12. Tunuguntla A, Sullivan MJ. Monitoring quality of flexible endoscope disinfection by microbiologic surveillance cultures. Tenn Med 2004; 97: 453-456
13. Aanstoos CM. Endoscopes: clean clear through? Am J Nurs 1992; 92: 14
14. Urayama S, Kozarek RA, Sumida S et al. Mycobacteria and glutaraldehyde: is high-level disinfection of endoscopes possible? Gastrointest Endosc 1996; 43: 451-456
15. Vesley D, Melson J, Stanley P. Microbial bioburden in endoscope reprocessing and an in-use evaluation of the high-level disinfection capabilities of Cidex PA. Gastroenterol Nuts 1999: 22: 63-68
16. Nelson DB. Infectious disease complications of GI endoscopy: part II, exogenous infections. Gastrointest Endosc 2003; 57: 695-711
17. Gorse GJ, Messner RL. Infection control practices in gastrointestinal endoscopy in the United States: a national survey. Gastroenterol Nurs 1991; 14: 72-79
18. Seoane-Vazquez E, Rodriguez-Monguio R, Visaria J et al. Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic burden. Curr Med Res Opin 2006; 22: 2007-2021
19. Alvarado CJ, Reichelderfer M. APIC guideline for infection prevention and control in flexible endoscopy. Association for Professionals in Infection Control. Am J Infect Control 2000; 28: 138-155
20. Food and Drug Administration. Manufacturer and User Facility Device Experience Database (MAUDE). Food and Drug Administration, 2005 [accessed 2005 July 20]. http://www.fda.goy/cdrh/maude.html
21. Food and Drug Administration. Medical Device Reporting (MDR): General Information. Food and Drug Administration, 2002 [accessed 2005, July 20]. http://www.fda.gov/cdrh/mdr/mdr-general.html
22. Food and Drug Administration. FDA Enforcement Report Index 2005 [accessed 2005, July 20]. http://www.fda.gov/opacom/Enforce.html
23. Lautenbach E, Woeltje K (eds). Practical handbook for healthcare epidemiologists, 2nd edn. Thorofare, New Jersey: Slack Inc, 2004
24. Manzoor SE, Lambert PA, Griffiths PA et al. Reduced glutaraldehyde susceptibility in Mycobacterium chelonae associated with altered cell wall polysaccharides. J Antimicrob Chemother 1999; 43: 759-765
25. Archibald L, Phillips L, Monnet D et al. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-215
26. Ward MM, Diekema DJ, Yankey JW et al. Implementation of strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in U.S. hospitals. Infect Control Hosp Epidemiol 2005; 26: 21-30
27. Goldmann DA, Weinstein RA, Wenzel RP et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275: 234-240